A Novel Combined Nomogram Model for Predicting the Pathological Complete Response to Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Specific Type: Real-World Study

被引:1
|
作者
Zhu, Xuelin [1 ,2 ,3 ]
Shen, Jing [1 ,2 ]
Zhang, Huanlei [4 ]
Wang, Xiulin [2 ,5 ]
Zhang, Huihui [2 ]
Yu, Jing [2 ]
Zhang, Qing [2 ]
Song, Dongdong [2 ]
Guo, Liping [6 ]
Zhang, Dianlong [7 ]
Zhu, Ruiping [8 ]
Wu, Jianlin [2 ]
机构
[1] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China
[2] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian, Peoples R China
[3] Qingzhou Peoples Hosp, Dept Ultrasound, Weifang, Peoples R China
[4] Yidu Cent Hosp Weifang, Dept Radiol, Weifang, Peoples R China
[5] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Sch Biomed Engn, Dalian, Peoples R China
[6] Dalian Univ, Affiliated Zhongshan Hosp, Dept Ultrasound, Dalian, Peoples R China
[7] Dalian Univ, Affiliated Zhongshan Hosp, Dept Breast & Thyroid Surg, Dalian, Peoples R China
[8] Dalian Univ, Affiliated Zhongshan Hosp, Dept Pathol, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
multiparametric MRI; radiomics; neoadjuvant chemotherapy; invasive breast carcinoma of no specific type; pathologic complete response; MRI; STAGE;
D O I
10.3389/fonc.2022.916526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo explore the value of a predictive model combining the multiparametric magnetic resonance imaging (mpMRI) radiomics score (RAD-score), clinicopathologic features, and morphologic features for the pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in invasive breast carcinoma of no specific type (IBC-NST). MethodsWe enrolled, retrospectively and consecutively, 206 women with IBC-NST who underwent surgery after NAC and obtained pathological results from August 2018 to October 2021. Four RAD-scores were constructed for predicting the pCR based on fat-suppression T2-weighted imaging (FS-T2WI), diffusion-weighted imaging (DWI), contrast-enhanced T1-weighted imaging (T1WI+C) and their combination, which was called mpMRI. The best RAD-score was combined with clinicopathologic and morphologic features to establish a nomogram model through binary logistic regression. The predictive performance of the nomogram was evaluated using the area under receiver operator characteristic (ROC) curve (AUC) and calibration curve. The clinical net benefit of the model was evaluated using decision curve analysis (DCA). ResultsThe mpMRI RAD-score had the highest diagnostic performance, with AUC of 0.848 among the four RAD-scores. T stage, human epidermal growth factor receptor-2 (HER2) status, RAD-score, and roundness were independent factors for predicting the pCR (P < 0.05 for all). The combined nomogram model based on these factors achieved AUCs of 0.930 and 0.895 in the training cohort and validation cohort, respectively, higher than other models (P < 0.05 for all). The calibration curve showed that the predicted probabilities of the nomogram were in good agreement with the actual probabilities, and DCA indicated that it provided more net benefit than the treat-none or treat-all scheme by decision curve analysis in both training and validation datasets. ConclusionThe combined nomogram model based on the mpMRI RAD-score combined with clinicopathologic and morphologic features may improve the predictive performance for the pCR of NAC in patients with IBC-NST.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
    R L Jones
    S R Lakhani
    A E Ring
    S Ashley
    G Walsh
    I E Smith
    British Journal of Cancer, 2006, 94 : 358 - 362
  • [22] Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survival
    Antonini, Marcelo
    Mattar, Andre
    Richter, Fernanda Grace Bauk
    Pannain, Gabriel Duque
    Teixeira, Marina Diogenes
    Amorim, Andressa Goncalves
    Ferraro, Odair
    Lopes, Reginaldo Coelho Guedes
    Gebrim, Luiz Henrique
    Real, Juliana Monte
    BREAST, 2023, 72
  • [23] Pathological complete response rates with the addition of carboplatin to standard neoadjuvant chemotherapy in a cohort of real-world patients with triple negative breast cancer
    Ramalho, S.
    dA Natal, R.
    Cardoso Filho, C.
    Xavier, M. B.
    da Silva, A. E. R.
    Silva, L. R.
    Vasconcelos, V.
    Reinert, T.
    Coelho, G. P.
    Silva, G. R. dP
    dos Santos, C. C.
    CANCER RESEARCH, 2019, 79 (04)
  • [24] Nomogram for the Pathological Complete Response After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients
    Shan, Liping
    Xu, Hanfeng
    Piao, Chengri
    Liu, Zhen
    Xie, Shuang
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 589 - 597
  • [25] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Chen, Xi
    Zhou, Zhiguo
    CANCER RESEARCH, 2024, 84 (03)
  • [26] Real-world assessment of the effect of impact of tumor size on pathological complete response rates in triple negative breast cancer after neoadjuvant chemotherapy
    Rala de Paula, Bruno Henrique
    Kumar, Sanjeev
    Morosini, Fabiola Marques
    Martins Calabria Cardoso, Debora Evelyn
    Moreira de Sousa, Carlos Augusto
    Crocamo, Susanne
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (06)
  • [27] Can body mass index be a complete pathological response predictor in breast cancer patients submitted to neoadjuvant chemotherapy? A real-world data trial
    Richter, Fernanda Grace Bauk
    Mattar, Andre
    Antonini, Marcelo
    Real, Juliana
    Gebrim, Luis Henrique
    Lopes, Reginaldo Coelho
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Nomogram for predicting axillary lymph node pathological complete response after neoadjuvant chemotherapy in node-positive breast cancer patients
    Wang, W.
    Wang, X.
    Liu, J.
    Wang, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] A Novel Multiparameter Biomarker of Pathological Response for NSCLC Receiving Neoadjuvant Immunotherapy: A Real-world Study
    Wu, S.
    Zhou, H.
    Zhan, W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S58 - S58
  • [30] Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Choi, S. J.
    Park, K. J.
    Heo, C.
    Park, B. W.
    Kim, M.
    Kim, J. K.
    CLINICAL RADIOLOGY, 2021, 76 (08) : 627.e13 - 627.e21